⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18330879 | 0.72 | — | — | |
| SCHEMBL7841754 | 0.69 | — | — | |
| SCHEMBL67955 | 0.69 | — | — | |
| SCHEMBL5648777 | 0.67 | — | — | |
| SCHEMBL27686715 | 0.62 | — | — | |
| SCHEMBL13166791 | 0.62 | — | — | |
| SCHEMBL29012420 | 0.62 | — | — | |
| SCHEMBL28898039 | 0.60 | — | — | |
| SCHEMBL28218370 | 0.59 | — | — | |
| SCHEMBL24697664 | 0.58 | OPRK1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116057045-A | Fibroblast growth factor receptor kinase inhibitors | 金耐特生物制药公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-105392484-A | Combination of imidazopyridazine derivatives with mitotic agents for the treatment of cancer | Bayer Pharma AG | 2016-03-09 | — | — | CN | disclosed |
| CN-103038235-B | Substituted imidazopyrazines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-07-29 | — | — | CN | disclosed |